Chronic Use of PPI and H2 Antagonists Decreases the Risk of Pouchitis After IPAA for Ulcerative Colitis

Lisa Poritz, Rishabh Sehgal, Arthur Berg, Lacee J. Laufenberg Puopolo, Christine Choi, Emmanuelle Williams

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Introduction: Bacteria have been implicated in the development of pouchitis after ileal pouch anal anastomosis. The change in gastric pH with the use of proton pump inhibitors and H2 antagonists may lead to alteration of enteric bacteria. We hypothesized that chronic use of these medications would decrease the incidence of pouchitis. Methods: Patients who had undergone ileal pouch anal anastomosis for ulcerative colitis were classified by history of pouchitis. Patients were further classified by their use of proton pump inhibitors, H2 blockers, antacids, and other known risk factors for pouchitis. Results: Eighty-five patients were identified. There was a statistically significant increase in the use of daily acid suppression in patients without pouchitis. There was also a statistically significant increase in the use of antacids in patients without pouchitis. Occasional use of acid suppression did not alter the rate of pouchitis. Conclusions: Our data suggest that the daily use of proton pump inhibitors, H2 antagonists, or antacids is associated with a decreased risk of pouchitis in ulcerative colitis. Occasional use of these agents did not seem to afford the same protection. These data suggest that altering the pH of the gastrointestinal tract may influence the development of pouchitis.

Original languageEnglish (US)
Pages (from-to)1027-1031
Number of pages5
JournalJournal of Gastrointestinal Surgery
Volume17
Issue number6
DOIs
StatePublished - Mar 1 2013

Fingerprint

Pouchitis
Ulcerative Colitis
Antacids
Proton Pump Inhibitors
Colonic Pouches
Acids
Enterobacteriaceae
Gastrointestinal Tract
Stomach
Bacteria

All Science Journal Classification (ASJC) codes

  • Surgery
  • Gastroenterology
  • Medicine(all)

Cite this

@article{7f4e44256c8f4d76bfa6f88cc752dbf1,
title = "Chronic Use of PPI and H2 Antagonists Decreases the Risk of Pouchitis After IPAA for Ulcerative Colitis",
abstract = "Introduction: Bacteria have been implicated in the development of pouchitis after ileal pouch anal anastomosis. The change in gastric pH with the use of proton pump inhibitors and H2 antagonists may lead to alteration of enteric bacteria. We hypothesized that chronic use of these medications would decrease the incidence of pouchitis. Methods: Patients who had undergone ileal pouch anal anastomosis for ulcerative colitis were classified by history of pouchitis. Patients were further classified by their use of proton pump inhibitors, H2 blockers, antacids, and other known risk factors for pouchitis. Results: Eighty-five patients were identified. There was a statistically significant increase in the use of daily acid suppression in patients without pouchitis. There was also a statistically significant increase in the use of antacids in patients without pouchitis. Occasional use of acid suppression did not alter the rate of pouchitis. Conclusions: Our data suggest that the daily use of proton pump inhibitors, H2 antagonists, or antacids is associated with a decreased risk of pouchitis in ulcerative colitis. Occasional use of these agents did not seem to afford the same protection. These data suggest that altering the pH of the gastrointestinal tract may influence the development of pouchitis.",
author = "Lisa Poritz and Rishabh Sehgal and Arthur Berg and {Laufenberg Puopolo}, {Lacee J.} and Christine Choi and Emmanuelle Williams",
year = "2013",
month = "3",
day = "1",
doi = "10.1007/s11605-013-2172-y",
language = "English (US)",
volume = "17",
pages = "1027--1031",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "6",

}

Chronic Use of PPI and H2 Antagonists Decreases the Risk of Pouchitis After IPAA for Ulcerative Colitis. / Poritz, Lisa; Sehgal, Rishabh; Berg, Arthur; Laufenberg Puopolo, Lacee J.; Choi, Christine; Williams, Emmanuelle.

In: Journal of Gastrointestinal Surgery, Vol. 17, No. 6, 01.03.2013, p. 1027-1031.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chronic Use of PPI and H2 Antagonists Decreases the Risk of Pouchitis After IPAA for Ulcerative Colitis

AU - Poritz, Lisa

AU - Sehgal, Rishabh

AU - Berg, Arthur

AU - Laufenberg Puopolo, Lacee J.

AU - Choi, Christine

AU - Williams, Emmanuelle

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Introduction: Bacteria have been implicated in the development of pouchitis after ileal pouch anal anastomosis. The change in gastric pH with the use of proton pump inhibitors and H2 antagonists may lead to alteration of enteric bacteria. We hypothesized that chronic use of these medications would decrease the incidence of pouchitis. Methods: Patients who had undergone ileal pouch anal anastomosis for ulcerative colitis were classified by history of pouchitis. Patients were further classified by their use of proton pump inhibitors, H2 blockers, antacids, and other known risk factors for pouchitis. Results: Eighty-five patients were identified. There was a statistically significant increase in the use of daily acid suppression in patients without pouchitis. There was also a statistically significant increase in the use of antacids in patients without pouchitis. Occasional use of acid suppression did not alter the rate of pouchitis. Conclusions: Our data suggest that the daily use of proton pump inhibitors, H2 antagonists, or antacids is associated with a decreased risk of pouchitis in ulcerative colitis. Occasional use of these agents did not seem to afford the same protection. These data suggest that altering the pH of the gastrointestinal tract may influence the development of pouchitis.

AB - Introduction: Bacteria have been implicated in the development of pouchitis after ileal pouch anal anastomosis. The change in gastric pH with the use of proton pump inhibitors and H2 antagonists may lead to alteration of enteric bacteria. We hypothesized that chronic use of these medications would decrease the incidence of pouchitis. Methods: Patients who had undergone ileal pouch anal anastomosis for ulcerative colitis were classified by history of pouchitis. Patients were further classified by their use of proton pump inhibitors, H2 blockers, antacids, and other known risk factors for pouchitis. Results: Eighty-five patients were identified. There was a statistically significant increase in the use of daily acid suppression in patients without pouchitis. There was also a statistically significant increase in the use of antacids in patients without pouchitis. Occasional use of acid suppression did not alter the rate of pouchitis. Conclusions: Our data suggest that the daily use of proton pump inhibitors, H2 antagonists, or antacids is associated with a decreased risk of pouchitis in ulcerative colitis. Occasional use of these agents did not seem to afford the same protection. These data suggest that altering the pH of the gastrointestinal tract may influence the development of pouchitis.

UR - http://www.scopus.com/inward/record.url?scp=84877761512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877761512&partnerID=8YFLogxK

U2 - 10.1007/s11605-013-2172-y

DO - 10.1007/s11605-013-2172-y

M3 - Article

C2 - 23532599

AN - SCOPUS:84877761512

VL - 17

SP - 1027

EP - 1031

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 6

ER -